When analyzed in GCB- and ABC-DLBCL subsets separately, patients with p63+ ABC-DLBCL showed significantly better PFS (P=0.0097) and a trend of better OS (P=0.08) compared with p63− ABC-DLBCL patients. The gene discussed is ABCB6; the disease is diffuse large B-cell lymphoma.